OTC · Financial Statements
Kaken Pharmaceutical Co., Ltd. (KKPCF) Financial Statements
$26.00
OTC: KKPCF
Market Cap $984.58M
Overview Financials Dividend Kaken Pharmaceutical Co., Ltd. most recently reported annual revenue of $77.4B, net profit of $2.2B, revenue has compounded at 0.6% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2022 2023 2024 2025 2026 Revenue $76.0B $73.0B $72.0B $94.0B $77.4B Operating Profit $17.1B $8.0B $9.5B $21.0B $-905.0M Net Profit $9.5B $5.4B $8.0B $13.9B $2.2B EPS $251.44 $144.79 $212.66 $365.42 $57.52 Op Margin 22.4% 11.0% 13.2% 22.4% -1.2%
Balance Sheet (USD)
Metric 2022 2023 2024 2025 2026 Total Assets $165.2B $166.3B $171.6B $190.4B $179.3B Total Liabilities $26.9B $29.5B $27.9B $37.8B $30.8B Cash $61.0B $59.6B $50.6B $54.1B $45.0B Borrowings $3.9B $3.9B $3.9B $3.9B $3.9B
Cash Flow (USD)
Metric 2022 2023 2024 2025 2026 Operating Cash Flow $13.3B $9.3B $2.6B $29.8B $-11.1B Investing Cash Flow $-11.1B $-4.8B $-8.0B $-24.0B $-2.7B Financing Cash Flow $-2.4B $-1.3B $-1.0M $-5.9B $-2.4B Net Cash Flow $-2.7B $-365.0M $-8.9B $4.8B $-29.7B Free Cash Flow $10.1B $7.0B $410.0M $25.4B $-14.2B
Valuation & Return Ratios
Metric Value PEG Ratio -0.41 EV / EBITDA 18.62 FCF Yield 0.00% Quick Ratio 3.60 Interest Coverage -19.98 Return 1Y -85.36% Return 3Y -99.27% Return 5Y —
Screens featuring this stock